Cellanome provides an automated platform for live-cell phenotypic and functional assays that analyze single cells at scale. It runs high-throughput experiments that integrate with existing lab workflows, collecting multi-parameter data and allowing iterative testing under different conditions. The system emphasizes single-cell granularity, scalable data collection, and easy assay customization without major process changes. Its goal is to help life sciences, medical research, pharmaceutical, and biotech teams gain deeper cellular insights to accelerate discovery through a platform-as-a-service model.
Company Size
51-200
Company Stage
Series C
Total Funding
$276.9M
Headquarters
Foster City, California
Founded
2020
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?